Vertiflex Superion Spacer Panel Reset To Give FDA More Review Time
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopaedics and Rehabilitation Devices Panel had planned to consider Vertiflex's PMA for its Superion interspinous spacer device on Dec. 12, but the agency postponed the meeting to Feb. 20 give it more time to review device information.